期刊文献+

鸦胆子油乳联合尼莫斯汀治疗颅内恶性胶质瘤临床疗效观察 被引量:2

The study of brucea oil emulsion joint nimustine in the treatment of malignant gliomas
原文传递
导出
摘要 目的探讨鸦胆子油乳联合尼莫斯汀治疗恶性胶质瘤患者的临床疗效。方法选取我院112例胶质瘤患者,依据入院先后顺序分为实验组和对照组,每组56例。实验组应用鸦胆子油乳注射液联合尼莫斯汀,对照组单纯应用尼莫斯汀。两组均以1个月为一个化疗周期,均完成4个化疗周期以上,观察临床疗效、副作用和生存质量评分变化。结果两组临床疗效相比实验组总有效率为55.3%,对照组总有效率为25%,试验组优于对照组,差异有统计学意义(P<0.05);实验组生活质量改善率为71.4%,对照组为35.7%,实验组明显高于对照组,差异有统计学意义(P<0.05)。实验组中骨髓抑制率及肝功能损害低于对照组,两组相比P<0.05.结论鸦胆子油乳注射液联合尼莫斯汀治疗胶质瘤能提高疗效及改善胶质瘤患者的生活质量,降低副作用. Objective To explore the clinical efficacy of Brucea oil emulsion joint nimustine in treatment the patients with malignant glioma.Methods Select 112 cases of glioma patients from my hospital,according to the order of admission into experimental and control groups,56 cases in each group.Experimental group used brucea oil emulsion injection and nimustine,control group oniy used nimustine.The two groups are one month for a chemotherapy cycle,they have completed four chemotherapy cycles.To observe the chage of clinical efficacy、toxicity and quality of life score.Results The two groups clinical efficacy copared,the total effective rate is 55.3%in the experimental group,in the control group is 25%,the test group better than the control group,the difference is statistically significant(P〈0.05);Improve the quality of life in the experimental group is 71.4%,35.7%in the control group,the experimental group is significantly higher,the difference is statistically significant(P〈0.05);Bone marrow suppression and liver dysfunction in experimental group are lower than control group,the two groups compared P〈0.05。Conclusion Javanica oil emulsion injection combined with nimustine can improve the efficacy of glioma and improve the quality of life in patients with glioma,reduce side effects.
出处 《立体定向和功能性神经外科杂志》 2015年第6期340-342,共3页 Chinese Journal of Stereotactic and Functional Neurosurgery
关键词 鸦胆子油乳注射液 尼莫斯汀 恶性胶质瘤 Javanica oil emulsion injection Nimustine Malignant gliomas
  • 相关文献

参考文献11

二级参考文献55

  • 1陈涛利,卞翠翠,杨雷,刘子玲.早期高危宫颈癌患者术后不同治疗方案的临床疗效[J].中国老年学杂志,2015,35(1):55-57. 被引量:25
  • 2岳永玉,尹慧清.骨桥蛋白在人脑胶质瘤中的表达[J].实用诊断与治疗杂志,2006,20(7):516-517. 被引量:2
  • 3张俊平,魏大年,赛克,牟永告,张湘衡,王涤宇,陈忠平.替莫唑胺治疗国人恶性脑胶质瘤:31例临床疗效分析[J].中国新药与临床杂志,2007,26(7):534-538. 被引量:5
  • 4De Angelis LM, Posner JB. Cancer of the centrol nervous system and pituitary gland//In: Lenhard RE, Osteen RT, Gansler T(eds). Clinical Oneology[M]. 3th ed. Atlanta: American cancer society (Emily pualwan), 2003: 653-703.
  • 5Asthagiri AR, Pouratian N, Sherman J, et al. Advances in brain tumor surgery[J]. Neurol Clin, 2007, 25(4): 975-1003.
  • 6Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review [J]. Radiother Oncol, 2002, 64(3): 259-273.
  • 7Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas [J]. Int J Radiat Oncol Boil Phys, 1979, 5(10): 1725-1731.
  • 8Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astroeytoma. The Medical Research Council Brain Tumour Working Party[J]. Br J Cancer, 1991, 64(4): 769-774.
  • 9Pirtoli L, Rubino G, Marsili S, et al. Three-dimensional conformal radiotherapy, temozolomide chemotherapy, and high-dose fractionated stereotactic boost in a protocol-driven, postoperative treatment schedule for high-grade gliomas[J]. Tumori, 2009, 95(3): 329-337.
  • 10Cho KH, Kim JY, Lee SH, et al. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas[J]. Int J Radiat Oncol Biol Phys, 2010, 78(2): 390-397.

共引文献129

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部